Free <i>N</i>‐Acetylneuraminic Acid in Tissues in Salla Disease and the Enzymes Involved in Its Metabolism

Martin Renlund, Michael Chester, Arne Lundblad, Jaakko Parkkinen, Tom Krusius

European Journal of Biochemistry · 1983 · 45 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

Salla disease is a lysosomal storage disorder of unknown etiology, characterized biochemically by increased urinary excretion of N-acetylneuraminic acid. This compound has now been shown to occur in abnormally large amounts in liver and cultured skin fibroblasts from these patients. Quantification of N-acetylneuraminic acid was performed using a new gas-chromatography/mass spectrometric single-ion method which is sensitive and specific. No abnormalities in the activity of several enzymes involved in sialic acid metabolism (N-acetylneuraminate:pyruvate lyase, neuraminidase, CMP-N-acetylneuraminate N-acylneuraminohydrolase and CTP:N-acyl-neuraminate cytidylyltransferase) were demonstrable. A possible explanation for the defect is a malfunctioning active transport of N-acetylneuraminic acid across the lysosomal membrane.

References

31